Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Psychiatry and Clinical Neurosciences

• Publication date

  1996-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1440-1819.1996.tb01678.xPMID 9201760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reexamination of granulovacuolar degeneration

  2004cited by this paper
• Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site

  2004cited by this paper
• Phosphorylated tau immunoreactivity of granulovacuolar bodies (GVB) of Alzheimer's disease: localization of two amino terminal tau epitopes in GVB

  2004cited by this paper
• A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration

  2004cited by this paper
• Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*)

  1995cited by this paper
• Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.

  1995cited by this paper
• Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro

  1994cited by this paper
• Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

  1994cited by this paper
• New Patterns of Intraneuronal Accumulation of the Microtubular Binding Domain of tau in Granulovacuolar Degeneration

  1992cited by this paper
• A serine-->proline change in the Alzheimer's disease-associated epitope Tau 2 results in altered secondary structure, but phosphorylation overcomes the conformational gap.

  1992cited by this paper
• Granulovacuolar degeneration in the hippocampal cortex of aging and demented patients — a quantitative study

  1992cited by this paper
• Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases.

  1991cited by this paper
• Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.

  1991cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper
• Sequestration of tubulin in neurons in Alzheimer's disease.

  1986cited by this paper
• Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments.

  1985cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study

  1978cited by this paper
• Morphology of the aging brain, human and animal.

  1973cited by this paper
• Studies on the Formation of Autophagic Vacuoles in Neurons Treated with Spindle Inhibitors (Colchicine and Vinblastine)

  1970cited by this paper
• The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex.

  1968cited by this paper
• THE FINE STRUCTURE OF SOME INTRAGANGLIONIC ALTERATIONS

  1968cited by this paper

• A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer’s disease

  2023cites this paper
• Intraneuronal sortilin aggregation relative to granulovacuolar degeneration, tau pathogenesis and sorfra plaque formation in human hippocampal formation

  2022cites this paper
• The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease

  2021cites this paper
• Untangling the origin and function of granulovacuolar degeneration bodies in neurodegenerative proteinopathies

  2020cites this paper
• Dihydrotanshinone I Increase Amyloid-β Clearance and Decrease Tau Phosphorylation via Enhancing Autophagy

  2020cites this paper
• Granulovacuolar degeneration bodies are neuron-selective lysosomal structures induced by intracellular tau pathology

  2019cites this paper
• Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology

  2016influential citation
• Lithium Ameliorates Motor Disturbance by Enhancing Autophagy in Tauopathy Model Mice

  2015cites this paper
• MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

  2014cites this paper
• Hyperphosphorylation-Induced Tau Oligomers

  2013cites this paper
• Alzheimer’s Disease Pathology as a Clue to Pathogenesis

  2012influential citation
• O4‐11‐05: Long‐term oral lithium treatment attenuates motor disturbance in tauopathy model mice: Implications of autophagy promotion

  2012cites this paper
• Granulovacuolar degeneration bodies of Alzheimer's disease resemble late‐stage autophagic organelles

  2011cites this paper
• Neuropathological alterations in Alzheimer disease.

  2011cites this paper
• Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late‐stage autophagic organelles

  2011cites this paper
• Granulovacuolar Degenerations Appear in Relation to Hippocampal Phosphorylated Tau Accumulation in Various Neurodegenerative Disorders

  2011cites this paper
• Neuropathology of Alzheimer's disease.

  2010cites this paper
• Tau in Alzheimer disease and related tauopathies.

  2010cites this paper
• Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus.

  2010cites this paper
• Anti-Inflammatory Properties of Acetylcholinesterase Inhibitors Administred in Alzheimers Disease

  2009cites this paper
• Mechanisms of tau-induced neurodegeneration

  2009cites this paper
• Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease

  2006cites this paper
• Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo

  2006cites this paper
• Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer’s disease and tauopathies to granulovacuolar degeneration bodies

  2006cites this paper
• Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology

  2003cites this paper
• Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus

  2002cites this paper
• Types of Age-Related Brain Lesions and Relationship to Neuropathologic Diagnostic Systems of Alzheimer's Disease

  2001cites this paper
• Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease.

  1998cites this paper
• This Work Is Licensed under a Creative Commons Attribution 4.0 International License Re-examining Tau-immunoreactive Pathology in the Population: Granulovacuolar Degeneration and Neurofibrillary Tangles and the Cambridge City Over-75s Cohort Collaboration

  year unknowncites this paper